Operating expenses of Genmab 2017-2023
This statistic shows the operating expenses of Danish biotechnology company Genmab from 2017 to 2023. From 2017 onwards the company reported increasing operating expenses. The amount peaked in 2023, at around 11 billion Danish kroner. Genmab is a Danish biotechnology company founded in 1999. The company is specializing in therapeutics for cancer treatment.